A role for a renin–angiotensin system (RAS) in VEGF inhibitor-induced hypertension was also hypothesized, but most of the evidence available in both human and experimental models showed a counter-regulative suppression of RAS in this setting [105,106]. This evidence concerns the gene VEGFA and Hypertension.